Threshold Concept of Collagen Deposition as a Marker of Myocardial Interstitial Fibrosis in Atrial Fibrillation Cases

loading.default
thumbnail.default.alt

item.page.date

item.page.journal-title

item.page.journal-issn

item.page.volume-title

item.page.publisher

Genius Journals

item.page.abstract

Procollagen type I carboxyterminal propeptide (P1CP) and carboxy-terminal telopeptide of collagen type I (C1TP) were presented as peptides that reflect collagen synthesis and degradation and offer a much more helpful tool for detecting ECM alterations at a distance. In past years, clinical trials have been conducted to evaluate the use of these peptides as either prognostic or diagnostic biomarkers in patients with heart failure (HF). This study would investigate whether the combination of a collagen turnover marker and a collagen deposition marker is associated with different subtypes of atrial fibrillation (AF). As there is a new trend to investigate the roles of these markers in other cardiac diseases, this study would investigate whether the combination of the collagen turnover marker and the collagen deposition marker is associated with different subtypes of atrial fibrillation

item.page.description

item.page.citation

item.page.collections

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced